Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis.
cerebrospinal fluid
postneurosurgical ventriculitis/meningitis
presepsin
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
06
2021
accepted:
20
07
2021
entrez:
5
8
2021
pubmed:
6
8
2021
medline:
6
8
2021
Statut:
epublish
Résumé
To evaluate the diagnostic and prognostic value of CSF presepsin levels in patients with postneurosurgical ventriculitis/meningitis (PNVM). We conducted a case-control study to achieve our aims. First, we prospectively enrolled patients who had undergone neurosurgery in Beijing Tiantan Hospital from June to November 2020 and measured the CSF levels of 8 biomarkers, including presepsin and other meningitis biomarkers. The diagnostic and prognostic accuracies of presepsin levels were evaluated by determining the values for the area under the receiver operating characteristic curve (AUC). Two hundred thirty-nine patients were enrolled in this study; 34 were diagnosed with confirmed ventriculitis/meningitis (cVM), 138 were classified as probable ventriculitis/meningitis (pVM), and the others were rejected ventriculitis/meningitis (rVM). Presepsin levels effectively diagnose cVM and predict the outcomes of patients with PNVM, with thresholds of 1257.4 pg/mL and 1276.2 pg/mL and AUCs of 0.746 and 0.825, respectively. Furthermore, a joint analysis with CSF lactate (C-Lac) levels shows that the AUCs of the two markers increased to 0.856 and 0.872, respectively. The rapid diagnosis and prediction of the clinical outcome is important in neurosurgery. CSF presepsin levels are an impressive diagnostic and prognostic biomarker for meningitis, and when combined with C-Lac, they indeed improve the diagnostic and predictive efficiency of PNVM.
Identifiants
pubmed: 34349525
doi: 10.2147/IDR.S325635
pii: 325635
pmc: PMC8326282
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2901-2909Informations de copyright
© 2021 Zheng et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Clin Pharmacol Ther. 2021 Aug;110(2):346-360
pubmed: 33559152
BMC Infect Dis. 2019 Aug 30;19(1):760
pubmed: 31470804
Clin Chem Lab Med. 2020 Oct 23;:
pubmed: 33095752
Dis Markers. 2015;2015:701480
pubmed: 25852221
Clin Neurol Neurosurg. 2018 Sep;172:31-38
pubmed: 29960893
J Neurosurg. 2018 Jan;128(1):262-271
pubmed: 28298047
Clin Chim Acta. 2015 Oct 23;450:169-75
pubmed: 26296897
Surg Neurol Int. 2017 Jun 21;8:124
pubmed: 28713628
J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:12-4
pubmed: 21740312
J Clin Lab Anal. 2020 Oct;34(10):e23447
pubmed: 32638442
J Clin Lab Anal. 2020 Feb;34(2):e23069
pubmed: 31602678
BMC Urol. 2020 Mar 11;20(1):23
pubmed: 32160878
Clin Chim Acta. 2020 Jan;500:1-9
pubmed: 31593686
Indian J Crit Care Med. 2021 Feb;25(2):117-118
pubmed: 33707884
Int J Infect Dis. 2020 Jun;95:1-7
pubmed: 32251795
Front Neurol. 2018 Feb 15;9:58
pubmed: 29497398
J Pers Med. 2020 Dec 22;11(1):
pubmed: 33374939
Infect Drug Resist. 2020 Jul 06;13:2161-2170
pubmed: 32753912
Clin Infect Dis. 1999 Jul;29(1):69-74
pubmed: 10433567
Stud Health Technol Inform. 2021 May 27;281:774-778
pubmed: 34042683
Ther Clin Risk Manag. 2019 Jun 13;15:733-739
pubmed: 31354281
Crit Care Med. 2019 Jul;47(7):e538-e546
pubmed: 30985453
Ann Clin Biochem. 2019 Jan;56(1):133-140
pubmed: 30056757
Transl Pediatr. 2021 Jan;10(1):64-72
pubmed: 33633938
Minerva Anestesiol. 2020 Jul;86(7):768-776
pubmed: 32068982
J Clin Microbiol. 2015 Apr;53(4):1239-44
pubmed: 25653398
PLoS One. 2021 Jun 11;16(6):e0251518
pubmed: 34115780
J Infect Chemother. 2005 Oct;11(5):234-8
pubmed: 16258819
Am J Emerg Med. 2017 Apr;35(4):579-583
pubmed: 27979420